Annapolis Financial Services’s Biogen BIIB Stock Holding History

Annapolis Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.26K	Buy	+22	New	+$4.6K	﹤0.01%	331
2022 Q4	–	Sell	-2	Closed	-$1K	–	450
2022 Q3	$1K	Sell	2 -100	-98%	-$21.2K	﹤0.01%	468
2022 Q2	$21K	Hold	102	–	–	0.01%	239
2022 Q1	$21K	Hold	102	–	–	0.01%	250
2021 Q4	$24K	Hold	102	–	–	0.01%	245
2021 Q3	$29K	Hold	102	–	–	0.01%	210
2021 Q2	$35K	Hold	102	–	–	0.01%	184
2021 Q1	$29K	Hold	102	–	–	0.01%	186
2020 Q4	$25K	Buy	+102	New	+$26.3K	0.01%	187

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Annapolis Financial Services's BIIB Position: Q3 2024 in Review

Annapolis Financial Services opened a new position in Biogen (BIIB) in Q3 2024: 22 shares worth $4.26K. The stake represents ﹤0.01% of the portfolio and ranks #331 among its holdings. This is a return to the name: Annapolis Financial Services previously reported a position in BIIB as recently as Q3 2022.

Annapolis Financial Services first reported a position in BIIB in Q4 2020 and has held it in 9 quarters since. The position peaked at $35K in Q2 2021. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

Annapolis Financial Services held 22 shares of Biogen worth $4.26K as of Q3 2024.
Biogen was a new Annapolis Financial Services position in Q3 2024.
Biogen made up ﹤0.01% of Annapolis Financial Services's portfolio in Q3 2024, its #331 holding.
Annapolis Financial Services first reported a position in Biogen in Q4 2020 and has held it in 9 quarters since.
Annapolis Financial Services's Biogen position peaked at $35K in Q2 2021.
916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Annapolis Financial Services's 13F filing for Q3 2024, filed 16 Oct 2024.